These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6525661)

  • 1. In vitro dissolution profile and in vivo absorption study of sustained-release tablets containing chlorpheniramine maleate with water-insoluble glucan.
    Masumoto K; Matsumoto K; Yoshida A; Hayashi S; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3720-3. PubMed ID: 6525661
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained-release dosage forms containing chlorpheniramine maleate with water-insoluble glucan.
    Masumoto K; Matsumoto K; Yoshida A; Hayashi S; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1055-62. PubMed ID: 6744480
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo correlation for controlled-release formulation of d-chlorpheniramine maleate.
    Katori N; Okudaira K; Aoyagi N; Takeda Y; Uchiyama M
    J Pharmacobiodyn; 1991 Oct; 14(10):567-75. PubMed ID: 1818098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations.
    Mojaverian P; Radwanski E; Lin CC; Cho P; Vadino WA; Rosen JM
    Pharm Res; 1992 Apr; 9(4):450-6. PubMed ID: 1495888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of drugs by inclusion in plastic matrices. I. Dexchlorpheniramine maleate.
    Alfonso Zerquera HM; Bermudez Benitez E; De Armas Leyva R
    J Pharm Belg; 1983; 38(6):315-9. PubMed ID: 6674474
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a new controlled-release formulation of chlorpheniramine maleate using in vitro/in vivo correlations.
    Williams RL; Upton RA; Ball L; Braun RL; Lin ET; Liang-Gee W; Leeson LJ
    J Pharm Sci; 1991 Jan; 80(1):22-5. PubMed ID: 2013843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of regular and controlled-release chlorpheniramine products.
    Kotzan JA; Vallner JJ; Stewart JT; Brown WJ; Viswanathan CT; Needham TE; Dighe SV; Malinowski R
    J Pharm Sci; 1982 Aug; 71(8):919-23. PubMed ID: 7120098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of chlorpheniramine maleate from fatty acid ester matrix disks prepared by melt-extrusion.
    Prapaitrakul W; Sprockel OL; Shivanand P
    J Pharm Pharmacol; 1991 Jun; 43(6):377-81. PubMed ID: 1681047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between in vitro release and in vivo absorption of sustained-releasing tablets of neostigmine bromide].
    Luo W; Tan QY; Xiong HR; Zhao CJ; Zhang JQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):80-3. PubMed ID: 23600216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of chlorpheniramine in vivo after administration of d- and l-chlorpheniramine maleate].
    Fujiwara K; Iwamoto K; Kawai S; Sakamoto T
    Yakugaku Zasshi; 1989 Jan; 109(1):59-64. PubMed ID: 2732905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension technique.
    Mathir ZM; Dangor CM; Govender T; Chetty DJ
    J Microencapsul; 1997; 14(6):743-51. PubMed ID: 9394255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
    Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
    Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between dissolution in vitro and absorption in vivo of chuanping sustained release tablets].
    Cai YQ; Zhang ZP; Wu YH; Liu J; Xie JF; Chai JZ; Luo Y; Zhu SS
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(20):3473-8. PubMed ID: 24490556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpheniramine dissolution and relative urinary excretion from commercial products.
    Hsu HY; Ayres JW
    J Pharm Sci; 1989 Oct; 78(10):844-7. PubMed ID: 2600791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation optimization of sustained-release tablet of chlorpheniramine maleate by means of extreme vertices design and simultaneous optimization technique.
    Hirata M; Takayama K; Nagai T
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):741-6. PubMed ID: 1611687
    [No Abstract]   [Full Text] [Related]  

  • 16. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of chlorpheniramine maleate release from hydrophilic swellable polymer systems.
    Melendez M; Ghaly ES
    P R Health Sci J; 1997 Sep; 16(3):259-63. PubMed ID: 9431564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
    Fukuda M; Peppas NA; McGinity JW
    Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of chlorpheniramine maleate in the dog and rat.
    Peets EA; Weinstein R; Billard W; Symchowicz S
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):172-90. PubMed ID: 5072184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.